Therapeutic Choices in dMMR Recurrent or Advanced Endometrial Cancer

Factors Influencing Treatment Post-Chemo in dMMR Endometrial Cancer

During a Targeted Oncology™ Case-Based Roundtable™ event, Bradley Corr, MD, discussed the use of immune checkpoint inhibitors in patients with advanced endometrial cancer. This is the second of 2 articles based on this event.

Considerations for Ordering Biomarker Testing in Endometrial Cancer

During a Targeted Oncology™ Case-Based Roundtable™ event, Bradley Corr, MD, discussed the importance of mismatch repair deficiency testing and the value of next-generation sequencing in patients with advanced endometrial cancer.

Selecting Therapy for dMMR/MSI-H Endometrial Cancer After Chemotherapy

During a Targeted Oncology™ Case-Based Roundtable™ event, Jubilee Brown, MD, discussed the treatment options for a patient with endometrial cancer who relapsed following resection and again following a complete response to chemotherapy. This is the first of 2 articles based on this event.